Terason Partners with AmCad BioMed Corporation to Provide More Efficient Solutions to Assess and Diagnose Obstructive Sleep Apnea
AmCAD ® -UO combines artificial intelligence and advanced signal processing with Terason’s ultrasound imaging technology
BURLINGTON, MASS., and TAIPEI, TAIWAN, December 18, 2019—Terason, a leading global ultrasound imaging company based in Burlington, Mass., has partnered with AmCad BioMed Corporation to provide its ultrasound imaging technology for AmCad’s innovative Obstructive Sleep Apnea (OSA) solution, AmCAD®-UO.



